Mantiza, Genarose M.
HRN: 23-84-29 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFUROXIME 500MG (TAB)
10/06/2023
10/13/2023
PO
500mg
BID
UTI
Waiting Final Action